XENON PHARMACEUTICALS INC 98420N105 06/04/2024 COMPENSATION OF NAMED EXECUTIVE OFFICERS: APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE CORPORATION'S NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 600000 0 FOR 600000 FOR APELLIS PHARMACEUTICALS INC. 03753U106 06/05/2024 APPROVAL OF AN ADVISORY VOTE ON EXECUTIVE COMPENSATION. SECTION 14A SAY-ON-PAY VOTES ISSUER 1046872 0 FOR 1046872 FOR BEIGENE LTD 07725L102 06/05/2024 THAT, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE ...(DUE TO SPACE LIMITS, SEE PROXY MATERIAL FOR FULL PROPOSAL). SECTION 14A SAY-ON-PAY VOTES ISSUER 500000 0 FOR 500000 FOR BEIGENE LTD 07725L102 06/05/2024 THAT, ON A NON-BINDING, ADVISORY BASIS, THE FREQUENCY OF FUTURE ...(DUE TO SPACE LIMITS, SEE PROXY MATERIAL FOR FULL PROPOSAL). SECTION 14A SAY-ON-PAY VOTES ISSUER 500000 0 1 YEAR 500000 FOR AKERO THERAPEUTICS, INC 00973Y108 06/07/2024 TO CONSIDER AND ACT UPON A NON-BINDING, ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 1676733 0 FOR 1676733 FOR ATARA BIOTHERAPEUTICS, INC. 046513107 06/10/2024 TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT. SECTION 14A SAY-ON-PAY VOTES ISSUER 4150000 0 FOR 4150000 FOR IOVANCE BIOTHERAPEUTICS, INC. 462260100 06/11/2024 TO APPROVE, BY NON-BINDING ADVISORY VOTE, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 750000 0 FOR 750000 FOR ANAPTYSBIO, INC. 032724106 06/12/2024 TO CONDUCT A NON-BINDING ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE ACCOMPANYING MATERIALS. SECTION 14A SAY-ON-PAY VOTES ISSUER 1285217 0 FOR 1285217 FOR ROCKET PHARMACEUTICALS, INC. 77313F106 06/13/2024 APPROVAL OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, ON A NON-BINDING, ADVISORY BASIS. SECTION 14A SAY-ON-PAY VOTES ISSUER 1466051 0 FOR 1466051 FOR REVOLUTION MEDICINES, INC. 76155X100 06/20/2024 TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT PURSUANT TO THE COMPENSATION DISCLOSURE RULES OF THE SECURITIES AND EXCHANGE COMMISSION (SAY-ON-PAY&QUOT). &QUOT SECTION 14A SAY-ON-PAY VOTES ISSUER 3675582 0 FOR 3675582 FOR ZENTALIS PHARMACEUTICALS, INC. 98943L107 06/21/2024 TO APPROVE, ON AN ADVISORY (NON-BINDING) BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 450000 0 FOR 450000 FOR DBV TECHNOLOGIES S.A. 23306J101 05/16/2024 ADVISORY OPINION ON THE COMPENSATION OF NAMED EXECUTIVE OFFICERS OTHER THAN THE CHIEF EXECUTIVE SECTION 14A SAY-ON-PAY VOTES ISSUER 499668 0 FOR 499668 FOR DBV TECHNOLOGIES S.A. 23306J101 05/16/2024 OFFICER APPROVAL OF THE COMPENSATION POLICY FOR THE CHAIRMAN OF THE BOARD OF DIRECTORS FOR THE YEAR ENDING DECEMBER 31, 2024 SECTION 14A SAY-ON-PAY VOTES ISSUER 499668 0 FOR 499668 FOR DBV TECHNOLOGIES S.A. 23306J101 05/16/2024 APPROVAL OF THE COMPENSATION POLICY FOR THE DIRECTORS FOR THE YEAR ENDING DECEMBER 31, 2024 SECTION 14A SAY-ON-PAY VOTES ISSUER 499668 0 FOR 499668 FOR DBV TECHNOLOGIES S.A. 23306J101 05/16/2024 APPROVAL OF THE COMPENSATION POLICY FOR THE CHIEF EXECUTIVE OFFICER AND DEPUTY CHIEF EXECUTIVE OFFICER FOR THE YEAR ENDING DECEMBER 31, 2024 SECTION 14A SAY-ON-PAY VOTES ISSUER 499668 0 FOR 499668 FOR IDEAYA BIOSCIENCES, INC. 45166A102 05/31/2024 TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT ACCOMPANYING THIS NOTICE OF ANNUAL MEETING OF STOCKHOLDERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 2202812 0 FOR 2202812 FOR IDEAYA BIOSCIENCES, INC. 45166A102 05/31/2024 TO HOLD A NON-BINDING ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES BY STOCKHOLDERS ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 2202812 0 1 YEAR 2202812 FOR IMMUNOVANT INC 45258J102 08/21/2023 TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 39075 0 FOR 39075 FOR IVERIC BIO, INC. 46583P102 07/06/2023 TO APPROVE, BY NON-BINDING, ADVISORY VOTE, COMPENSATION THAT MAY BE PAID OR BECOME PAYABLE BY IVERIC TO ITS NAMED EXECUTIVE OFFICERS IN CONNECTION WITH THE MERGER. SECTION 14A SAY-ON-PAY VOTES ISSUER 220372 0 FOR 220372 FOR